Jeffry Adiwidjaja

10PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsCell physiologyEmergency medicineNutritional epidemiologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
Understanding Pharmacokinetic Variability of Pomalidomide: A Physiologically Based Pharmacokinetic Analysis of Disease-Related Physiology, Ethnicity, Hepatic Impairment, Food Effects, Drug Interactions, and Smoking.

|Feb 13, 2024
Physiologically Based Pharmacokinetic (PBPK) Model Predictions of Disease Mediated Changes in Drug Disposition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD).

Jeffry Adiwidjaja, Jessica Spires, Kim L R Brouwer

|Jul 07, 2023
Application of physiologically based pharmacokinetic modeling to understand real-world outcomes in patients receiving imatinib for chronic myeloid leukemia.

Josephine A Adattini, Jeffry Adiwidjaja, Annette S Gross

|Apr 23, 2022
Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS-CoV-2 Infection: A Case Study With Imatinib.

Jeffry Adiwidjaja, Josephine A Adattini, Alan V Boddy

|Apr 16, 2022
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH).

William A Murphy, Jeffry Adiwidjaja, Noora Sjöstedt

|Jan 20, 2022
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib.

Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan

Pageof 2

Frequent Collaborators

7 joint publications

Andrew J McLachlan

5 joint publications

Alan V Boddy

2 joint publications

Annette S Gross

2 joint publications

Kim L R Brouwer